LIVE @ #SIOSavannah | #Cryoablation in #RCC: Evidence from the #EuRECA Registry & Real-World Experience | Integrating EuRECA registry outcomes with US case-based experience and practical guidance on applying evidence to patient selection, procedural planning, and multidisciplinary RCC management. @SIO_Central #SIO2026
Headed to #SIO2026? Join us!
✔ Lunch symposium that sets the stage for PROACTIF by examining the evolving role of real-world evidence in HCC
✔ Cryoablation breakfast symposium
✔ Y-90 Dosimetry & hands-on workshop
✔ Booth demos of what’s next for the TheraSphere 360 Y-90 Management Platform
#SIOSavannah @SIO_Central
Advance your cryoablation expertise for oncologic and non-oncologic pain at our interactive, two-day Cryoneurolysis Masterclass this September.
Learn from top faculty—covering guidelines, clinical data, techniques, and hands-on training. Register now to secure your spot: https://t.co/zChpvmX3yN
#EDUCARE #MedicalEducation
#Cyroabalation
#oncology #MedicalTraining
#Cryoneurolysis
The EuRECA study shows cryoablation is a safe and effective treatment for patients with RCC. Of 1,207 patients with T1a RCC, cryoablation demonstrated a PTE of 97.9%. Join us in celebrating the strength and resilience of cancer survivors this month and raising awareness about advanced treatment options like cryoablation. See more on the EuRECA study here: https://t.co/K5qA7IWE5z
#EuRECAstudy #cryoablation #CancerSurvivorMonth
March is #KidneyCancerAwarenessMonth. In 2024, over 80,000 new cases of kidney cancer were diagnosed. To advance treatment options, we're excited to highlight the EuRECA study, the largest prospective, real-world multicenter study focusing on cryoablation for the treatment of RCC. Learn more about EuRECA here: https://t.co/FoFOnnvCXW
#EuRECAStudy #RCC #cryoablation #kidneycancer
With 1 in 5 people around the world developing cancer in their lifetime BSC IO&E is grateful to provide our physician partners with more options to treat patients including #TheraSphere for #HCC, freezing cancer cells to reduce pain with the Visual-ICE #cryoablation system and we look forward to welcoming Intera Oncology into the portfolio upon close of the transaction. Read further here: https://t.co/RC9ph5e8Pq
#interventionaloncology #WorldCancerDay2025 #WorldCancerDay
BSC Interventional Oncology & Embolization at #SIOVegas
Special thanks to @ZTBerman, @riadsalemIR, Parissa Tabrizian, MD; Francis Yao, MD; Juan Gimenez, MD;
@bayouteazy, David S. Wang, MD, FSIR; @BeauToskichMD, Diana Dinh, MD, MPH; @molecmedtweet and @kavikrishVIR for sharing your expertise!
#InterventionalOncology #Embolization #BostonScientific
We’ve entered into a definitive agreement to acquire @InteraOncology, a medical device company that provides a solution to treat metastatic colorectal cancer in the liver. Upon close, we look forward to welcoming the Intera Oncology team! https://t.co/mAweobtJgg